Latest news with #NewYorkLifeInvestments
Business Wire
06-05-2025
- Business
- Business Wire
New York Life Investments Launches NYLI MacKay Muni Short Duration ETF (MMSD)
NEW YORK--(BUSINESS WIRE)--New York Life Investments is announcing today the launch of its newest ETF, the NYLI MacKay Muni Short Duration ETF (NYSE: MMSD), an actively managed municipal bond ETF designed to provide attractive, tax-exempt income through a flexible short-duration strategy. Short-term municipal strategies already offer higher tax-equivalent income potential, and we believe they will outperform cash products this year. MMSD primarily invests in high quality, short-term municipal bonds with a target duration of 1-3 years. The Fund may allocate up to 20% of its assets to non-investment grade municipal securities, allowing for opportunistic positioning of the portfolio. The Fund is managed by the MacKay Municipal Managers team, led by Scott Sprauer, John Lawlor, Sanjit Gill and Vineeth Krishnakumar, a team focused on deep credit and market analysis with robust credit underwriting and thorough research experience. Sanjit Gill, Director at MacKay Shields, noted: 'In today's uncertain market environment, investors are looking for new ways to generate income while still appropriately managing risk. With normalizing interest rates, it's important to look outside of cash to pursue and capitalize on attractive income streams. Short-term municipal strategies already offer higher tax-equivalent income potential, and we believe they will outperform cash products this year.' The Fund expands the New York Life Investments suite of active muni-focused ETFs, which includes the NYLI MacKay Muni Insured ETF (MMIN), the NYLI MacKay Muni Intermediate ETF (MMIT), and the NYLI MacKay California Muni Intermediate ETF (MMCA). For more information on the fund and on New York Life Investments' full suite of ETF offerings, as well as insights and commentary on inflation and the current market environment, please visit our website here. To read our most recent MacKay Municipal Managers Outlook, visit our insights here. About New York Life Investments With over $754 billion in assets under management as of March 31, 2025, New York Life Investments, a Pensions & Investments' Top 30 Largest Money Manager*, is comprised of the affiliated global asset management businesses of its parent company, New York Life Insurance Company, and offers clients access to specialized, independent investment teams through its family of affiliated boutiques. New York Life Investments remains committed to clients through a combination of the diverse perspectives of its boutiques and a long-lasting focus on sustainable relationships. *New York Life Investment Management was ranked the 26 th largest institutional investment manager in Pensions & Investments ' Largest Money Managers 2024 published June 2024, based on worldwide institutional AUM as of 12/31/23. No direct or indirect compensation was paid for the creation and distribution of this ranking. About MacKay Municipal Managers™ MacKay Municipal Managers™ is a recognized leader in active municipal bond investing and is entrusted with $80 billion in assets under management, as of March 31, 2025. The team manages a suite of highly rated municipal bond solutions available in multiple vehicles. MacKay Municipal Managers™ is a fundamental relative-value bond manager that combines a top-down approach with bottom-up, credit research. Our investment philosophy is centered on the belief that strong long-term performance can be achieved with a relative value, research driven approach in a highly fragmented, inefficient municipal bond market. About MacKay Shields LLC MacKay Shields LLC (together with its subsidiaries, "MacKay")*, a New York Life Investments company, is a global asset management firm with $152 billion in assets under management** as of March 31, 2025. MacKay manages fixed income strategies for high-net worth individuals and institutional clients through separately managed accounts and collective investment vehicles including private funds, collective investment trusts, UCITS, ETFs, closed end funds and mutual funds. MacKay provides investors with specialty fixed income expertise across global fixed income markets including municipal bonds, high yield bonds, investment grade bonds, structured credit, and emerging markets debt. The MacKay Shields client experience provides investors direct access to senior investment professionals. For more information, please visit or follow us on Twitter or LinkedIn. * MacKay Shields is a wholly owned subsidiary of New York Life Investment Management Holdings LLC, which is wholly owned by New York Life Insurance Company. "New York Life Investments" is both a service mark, and the common trade name of certain investment advisers affiliated with New York Life Insurance Company. ** Assets under management (AUM) as of March 31, 2025 represents assets managed by MacKay Shields LLC and its subsidiaries but excludes certain accounts and other assets over which MacKay Shields continues to exercise discretionary authority to liquidate but which are no longer actively managed. For more insights from MacKay Municipal Managers™ and our New York Life Investments affiliates click here. About Risk: All Investments are subject to risk and will fluctuate in value. The Fund is a new fund. As a new fund, there can be no assurance that it will grow to or maintain an economically viable size, in which case it could ultimately liquidate. Municipal bond risks include the ability of the issuer to repay the obligation, the relative lack of information about certain issuers, and the possibility of future tax and legislative changes, which could affect the market for and value of municipal securities. Investing in below investment grade securities may carry a greater risk of nonpayment of interest or principal than higher-rated securities. The Fund is not a money market fund and does not attempt to maintain a stable NAV. The Fund's net asset value per share will fluctuate. There can be no guarantee that the Fund will achieve or maintain any particular level of yield. Bonds are subject to interest-rate risk and can lose principal value when interest rates rise. Bonds are also subject to credit risk, in which the bond issuer may fail to pay interest and principal in a timely manner. Consider the Funds' investment objectives, risks, charges and expenses carefully before investing. The prospectus and the statement of additional information include this and other relevant information about the Funds and are available by visiting or calling (888) 474-7725. Read the prospectus carefully before investing. Securities distributed by NYLIFE Distributors LLC, 30 Hudson Street, Jersey City, NJ 07302, Member FINRA/SIPC.
Yahoo
02-05-2025
- Business
- Yahoo
Is International Business Machines Corporation (IBM) the Best Dow Stock for the Next 12 Months?
We recently published a list of . In this article, we are going to take a look at where International Business Machines Corporation (NYSE:IBM) stands against other best and worst dow stocks for the next 12 months. The Dow Jones Industrial Average (DJIA), or the Dow, is a price-weighted index that has long been seen as a barometer of the health of the U.S. economy. After touching all-time highs in late November 2024, the index has corrected nearly 7% in 2025 (as of April 23) and is down 12% from its highs. Rightly so, the correction reflects several unfavourable developments, including economic uncertainties and geopolitical tensions weighing on economic growth. The market is expected to remain volatile as the trade and other aspects of the US administration's policy agenda play out. Amid this volatility, based on the potential for share price appreciation in the next 12 months, we have created a selection of the best and worst Dow stocks from the 30 Dow constituent stocks. If we analyse its trackable history from 1899, the Dow has fallen 7% or more on a single day twenty times. Of those, only seven occurred after the year 2000, and the 5.5% decline on April 5, 2025, doesn't count as one of those seven, or not even in the historical top twenty. So, technically, this correction was not as severe as earlier. From corrections post 2000, the sharp declines when Covid-19 struck were the most noticeable – Dow fell 7.8%, 10%, and 12% on 9, 12, and 16th March, respectively, and saw further significant declines in that year. That said, the current period remains one of the most confusing times for market participants, even for the larger players in the equity market, who remain uncertain about their estimates for the broader markets, such as the Dow. In a recent interview, Lauren Goodwin, Chief Market Strategist at New York Life Investments, emphasized that the fundamental picture remains cloudy and investors are still looking for clarity in macroeconomic fundamentals. Despite some positive economic data recently, policy uncertainty is limiting visibility. As more data is released, she believes markets are entering a sustained period of elevated volatility across equities and fixed income. In these testing times, investors should examine fundamentals more critically, preferring Dow stocks with earnings resilience, clear competitive advantages, and exposure to long-term, secular growth themes. On April 28, Stephanie Link, Hightower Advisors' chief investment strategist, shared her positive outlook on the stock market in an interview on CNBC. With major tech companies, consumer, and financial companies set to announce results, she believes that if corporate earnings remain strong, the recent market rebound could continue. Since early April, the market has recovered significantly, and she attributed the rally to better-than-expected profit margins and steady corporate performance. Although the prominent tech names aren't cheap in terms of valuation, she views the recent declines as long-term buying opportunities. While markets may remain volatile in the coming months, the best opportunities in the Dow over the next 12 months should come from stocks with strong pricing power and earnings momentum. Investors should stick to stocks with strong brands, recurring revenue models, and competitive moats, which enable them to navigate macro uncertainty. Since the Dow comprises large-cap companies across various industries, these stocks might perform better during sell-offs. To identify the best and worst Dow stocks, we began with the 30 constituent stocks of the DJIA Index. We then ranked these stocks in ascending order based on the consensus 1-year median potential upside. Additionally, we also include data on hedge funds holding stakes in these stocks, utilizing Insider Monkey's Q4 2024 hedge fund database to provide deeper insights into institutional investor trends. It is important to note here that the terms 'best' and 'worst' refer strictly to the relative upside potential and do not imply any fundamental strengths or weaknesses of the underlying are we interested in the stocks that hedge funds pile into? The reason is simple: our research has shown that we can outperform the market by imitating the top stock picks of the best hedge funds. Our quarterly newsletter's strategy selects 14 small-cap and large-cap stocks every quarter and has returned 363.5% since May 2014, beating its benchmark by 208 percentage points (see more details here). A closeup of a woman's hands typing rapidly on a laptop in a corporate office Business Machines Corporation (NYSE:IBM) is a technology company that provides integrated consulting, software, and infrastructure solutions by leveraging hybrid cloud and artificial intelligence. Over the last few years, International Business Machines Corporation (NYSE:IBM) has tried to refocus its strategic growth in areas such as automation, cybersecurity, and quantum computing. The company is particularly encouraged about hybrid cloud, where it sees as much as a $1.7 trillion global opportunity. It is also making robust progress in quantum computing and currently boasts of deploying more quantum systems than the rest of the world combined. In February, the company gave a long-term revenue growth guidance of 5%, including 10% software revenue growth, which supported the share price performance. Wamsi Mohan, an analyst at Bank of America Securities, recently corroborated these growth prospects. Despite the macroeconomic challenges, Wamsi reiterated his Buy rating on IBM with a price target of $270 in a report published around April 20. He lauded the company's strong YTD share price performance and attributed it to its recurring revenue streams and the mission-critical nature of its offerings. Among other drivers for his optimism, he counted strong growth in the software business, strategic acquisitions like HashiCorp, a healthy dividend yield, and the benefits from the Mainframe refresh cycle. Overall, IBM ranks 26th on our list of best and worst dow stocks for the next 12 months. While we acknowledge the potential of IBM as an investment, our conviction lies in the belief that AI stocks hold greater promise for delivering higher returns and doing so within a shorter time frame. There is an AI stock that went up since the beginning of 2025, while popular AI stocks lost around 25%. If you are looking for an AI stock that is more promising than IBM but that trades at less than 5 times its earnings, check out our report about this . READ NEXT: 20 Best AI Stocks To Buy Now and 30 Best Stocks to Buy Now According to Billionaires. Disclosure: None. This article is originally published at Insider Monkey. Sign in to access your portfolio
Yahoo
02-05-2025
- Business
- Yahoo
Is Amgen Inc. (AMGN) the Best Dow Stock for the Next 12 Months?
We recently published a list of . In this article, we are going to take a look at where Amgen Inc. (NASDAQ:AMGN) stands against other best and worst dow stocks for the next 12 months. The Dow Jones Industrial Average (DJIA), or the Dow, is a price-weighted index that has long been seen as a barometer of the health of the U.S. economy. After touching all-time highs in late November 2024, the index has corrected nearly 7% in 2025 (as of April 23) and is down 12% from its highs. Rightly so, the correction reflects several unfavourable developments, including economic uncertainties and geopolitical tensions weighing on economic growth. The market is expected to remain volatile as the trade and other aspects of the US administration's policy agenda play out. Amid this volatility, based on the potential for share price appreciation in the next 12 months, we have created a selection of the best and worst Dow stocks from the 30 Dow constituent stocks. If we analyse its trackable history from 1899, the Dow has fallen 7% or more on a single day twenty times. Of those, only seven occurred after the year 2000, and the 5.5% decline on April 5, 2025, doesn't count as one of those seven, or not even in the historical top twenty. So, technically, this correction was not as severe as earlier. From corrections post 2000, the sharp declines when Covid-19 struck were the most noticeable – Dow fell 7.8%, 10%, and 12% on 9, 12, and 16th March, respectively, and saw further significant declines in that year. That said, the current period remains one of the most confusing times for market participants, even for the larger players in the equity market, who remain uncertain about their estimates for the broader markets, such as the Dow. In a recent interview, Lauren Goodwin, Chief Market Strategist at New York Life Investments, emphasized that the fundamental picture remains cloudy and investors are still looking for clarity in macroeconomic fundamentals. Despite some positive economic data recently, policy uncertainty is limiting visibility. As more data is released, she believes markets are entering a sustained period of elevated volatility across equities and fixed income. In these testing times, investors should examine fundamentals more critically, preferring Dow stocks with earnings resilience, clear competitive advantages, and exposure to long-term, secular growth themes. On April 28, Stephanie Link, Hightower Advisors' chief investment strategist, shared her positive outlook on the stock market in an interview on CNBC. With major tech companies, consumer, and financial companies set to announce results, she believes that if corporate earnings remain strong, the recent market rebound could continue. Since early April, the market has recovered significantly, and she attributed the rally to better-than-expected profit margins and steady corporate performance. Although the prominent tech names aren't cheap in terms of valuation, she views the recent declines as long-term buying opportunities. While markets may remain volatile in the coming months, the best opportunities in the Dow over the next 12 months should come from stocks with strong pricing power and earnings momentum. Investors should stick to stocks with strong brands, recurring revenue models, and competitive moats, which enable them to navigate macro uncertainty. Since the Dow comprises large-cap companies across various industries, these stocks might perform better during sell-offs. To identify the best and worst Dow stocks, we began with the 30 constituent stocks of the DJIA Index. We then ranked these stocks in ascending order based on the consensus 1-year median potential upside. Additionally, we also include data on hedge funds holding stakes in these stocks, utilizing Insider Monkey's Q4 2024 hedge fund database to provide deeper insights into institutional investor trends. It is important to note here that the terms 'best' and 'worst' refer strictly to the relative upside potential and do not imply any fundamental strengths or weaknesses of the underlying are we interested in the stocks that hedge funds pile into? The reason is simple: our research has shown that we can outperform the market by imitating the top stock picks of the best hedge funds. Our quarterly newsletter's strategy selects 14 small-cap and large-cap stocks every quarter and has returned 363.5% since May 2014, beating its benchmark by 208 percentage points (see more details here). A pharmacist filling a prescription for a complex drug developed by the Inc. (NASDAQ:AMGN) is a pioneer in the biotechnology industry. It develops, manufactures, and sells innovative medicines for some of the most serious diseases, including cancer, heart disease, and osteoporosis. Close to ten of Amgen Inc.'s (NASDAQ:AMGN) products delivered at least double-digit sales growth, which helped the company's 2024 revenue climb 19% YoY to $33.4 billion. It expects to report revenue in the $34.3-35.7 billion range in 2025. In 2024, the company spent around $6 billion on R&D, up 25% year over year and equating to around 18.5% of total revenue. With that kind of R&D focus, the company has a strong pipeline of potentially best-in-class medicines across many therapeutic areas. The U.S. Food and Drug Administration (FDA) approved UPLIZNA as the first and only treatment for Immunoglobulin G4-related disease (IgG4-RD) in early March. This immune-mediated inflammatory condition can affect multiple organs. In their latest updates in the last two weeks, analysts from Bernstein, Piper Sandler, and Jefferies have reiterated their Buy rating on the stock. Overall, AMGN ranks 20th on our list of best and worst dow stocks for the next 12 months. While we acknowledge the potential of Dow stocks, our conviction lies in the belief that AI stocks hold greater promise for delivering higher returns and doing so within a shorter time frame. There is an AI stock that went up since the beginning of 2025, while popular AI stocks lost around 25%. If you are looking for an AI stock that is more promising than AMGN but that trades at less than 5 times its earnings, check out our report about this . READ NEXT: 20 Best AI Stocks To Buy Now and 30 Best Stocks to Buy Now According to Billionaires. Disclosure: None. This article is originally published at Insider Monkey. Sign in to access your portfolio
Yahoo
02-05-2025
- Business
- Yahoo
Is 3M Company (MMM) the Best Dow Stock for the Next 12 Months?
We recently published a list of . In this article, we are going to take a look at where 3M Company (NYSE:MMM) stands against other best and worst dow stocks for the next 12 months. The Dow Jones Industrial Average (DJIA), or the Dow, is a price-weighted index that has long been seen as a barometer of the health of the U.S. economy. After touching all-time highs in late November 2024, the index has corrected nearly 7% in 2025 (as of April 23) and is down 12% from its highs. Rightly so, the correction reflects several unfavourable developments, including economic uncertainties and geopolitical tensions weighing on economic growth. The market is expected to remain volatile as the trade and other aspects of the US administration's policy agenda play out. Amid this volatility, based on the potential for share price appreciation in the next 12 months, we have created a selection of the best and worst Dow stocks from the 30 Dow constituent stocks. If we analyse its trackable history from 1899, the Dow has fallen 7% or more on a single day twenty times. Of those, only seven occurred after the year 2000, and the 5.5% decline on April 5, 2025, doesn't count as one of those seven, or not even in the historical top twenty. So, technically, this correction was not as severe as earlier. From corrections post 2000, the sharp declines when Covid-19 struck were the most noticeable – Dow fell 7.8%, 10%, and 12% on 9, 12, and 16th March, respectively, and saw further significant declines in that year. That said, the current period remains one of the most confusing times for market participants, even for the larger players in the equity market, who remain uncertain about their estimates for the broader markets, such as the Dow. In a recent interview, Lauren Goodwin, Chief Market Strategist at New York Life Investments, emphasized that the fundamental picture remains cloudy and investors are still looking for clarity in macroeconomic fundamentals. Despite some positive economic data recently, policy uncertainty is limiting visibility. As more data is released, she believes markets are entering a sustained period of elevated volatility across equities and fixed income. In these testing times, investors should examine fundamentals more critically, preferring Dow stocks with earnings resilience, clear competitive advantages, and exposure to long-term, secular growth themes. On April 28, Stephanie Link, Hightower Advisors' chief investment strategist, shared her positive outlook on the stock market in an interview on CNBC. With major tech companies, consumer, and financial companies set to announce results, she believes that if corporate earnings remain strong, the recent market rebound could continue. Since early April, the market has recovered significantly, and she attributed the rally to better-than-expected profit margins and steady corporate performance. Although the prominent tech names aren't cheap in terms of valuation, she views the recent declines as long-term buying opportunities. While markets may remain volatile in the coming months, the best opportunities in the Dow over the next 12 months should come from stocks with strong pricing power and earnings momentum. Investors should stick to stocks with strong brands, recurring revenue models, and competitive moats, which enable them to navigate macro uncertainty. Since the Dow comprises large-cap companies across various industries, these stocks might perform better during sell-offs. To identify the best and worst Dow stocks, we began with the 30 constituent stocks of the DJIA Index. We then ranked these stocks in ascending order based on the consensus 1-year median potential upside. Additionally, we also include data on hedge funds holding stakes in these stocks, utilizing Insider Monkey's Q4 2024 hedge fund database to provide deeper insights into institutional investor trends. It is important to note here that the terms 'best' and 'worst' refer strictly to the relative upside potential and do not imply any fundamental strengths or weaknesses of the underlying are we interested in the stocks that hedge funds pile into? The reason is simple: our research has shown that we can outperform the market by imitating the top stock picks of the best hedge funds. Our quarterly newsletter's strategy selects 14 small-cap and large-cap stocks every quarter and has returned 363.5% since May 2014, beating its benchmark by 208 percentage points (see more details here). A specialized industrial laboratory, filled with high-tech machinery for producing abrasives.3M Company (NYSE:MMM) is a diversified global conglomerate that manufactures various products across industrial, safety, transportation, electronics, and consumer markets. On April 22, the company reported healthy Q1 2025 earnings results. Adjusted revenue for the quarter stood at $5.8 billion, up 1.5% organically, and modestly ahead of street estimates. The EPS of $1.88 was up 10% year-over-year and came substantially ahead of street expectations of $1.77. For FY 2025, the company reaffirmed its EPS guidance of $7.6 to $7.9 (in line with consensus at mid-point), including a $0.2-$0.4 impact from tariffs. The company is considering several measures to offset the effects of tariffs, including shifting its production bases, pricing actions, and optimizing networks. Following the results, an analyst at UBS published a report highlighting that the stock remains one of the Top Picks across the UBS coverage universe. Despite the company reiterating its guidance, the analyst increased his EPS estimates for FY 2025. He believes the guidance appears conservative, and there could be further upside to the company's estimates. Supported by the order trends and better organic growth, the analyst also estimates that the company would win back more market share in the coming years. He, therefore, reiterated a Buy rating with a price target of $184. Overall, MMM ranks 19th on our list of best and worst dow stocks for the next 12 months. While we acknowledge the potential of Dow stocks, our conviction lies in the belief that AI stocks hold greater promise for delivering higher returns and doing so within a shorter time frame. There is an AI stock that went up since the beginning of 2025, while popular AI stocks lost around 25%. If you are looking for an AI stock that is more promising than MMM but that trades at less than 5 times its earnings, check out our report about this . READ NEXT: 20 Best AI Stocks To Buy Now and 30 Best Stocks to Buy Now According to Billionaires. Disclosure: None. This article is originally published at Insider Monkey. Sign in to access your portfolio
Yahoo
02-05-2025
- Business
- Yahoo
Is The Boeing Company (BA) the Best Dow Stock for the Next 12 Months?
We recently published a list of . In this article, we are going to take a look at where The Boeing Company (NYSE:BA) stands against other best and worst dow stocks for the next 12 months. The Dow Jones Industrial Average (DJIA), or the Dow, is a price-weighted index that has long been seen as a barometer of the health of the U.S. economy. After touching all-time highs in late November 2024, the index has corrected nearly 7% in 2025 (as of April 23) and is down 12% from its highs. Rightly so, the correction reflects several unfavourable developments, including economic uncertainties and geopolitical tensions weighing on economic growth. The market is expected to remain volatile as the trade and other aspects of the US administration's policy agenda play out. Amid this volatility, based on the potential for share price appreciation in the next 12 months, we have created a selection of the best and worst Dow stocks from the 30 Dow constituent stocks. If we analyse its trackable history from 1899, the Dow has fallen 7% or more on a single day twenty times. Of those, only seven occurred after the year 2000, and the 5.5% decline on April 5, 2025, doesn't count as one of those seven, or not even in the historical top twenty. So, technically, this correction was not as severe as earlier. From corrections post 2000, the sharp declines when Covid-19 struck were the most noticeable – Dow fell 7.8%, 10%, and 12% on 9, 12, and 16th March, respectively, and saw further significant declines in that year. That said, the current period remains one of the most confusing times for market participants, even for the larger players in the equity market, who remain uncertain about their estimates for the broader markets, such as the Dow. In a recent interview, Lauren Goodwin, Chief Market Strategist at New York Life Investments, emphasized that the fundamental picture remains cloudy and investors are still looking for clarity in macroeconomic fundamentals. Despite some positive economic data recently, policy uncertainty is limiting visibility. As more data is released, she believes markets are entering a sustained period of elevated volatility across equities and fixed income. In these testing times, investors should examine fundamentals more critically, preferring Dow stocks with earnings resilience, clear competitive advantages, and exposure to long-term, secular growth themes. On April 28, Stephanie Link, Hightower Advisors' chief investment strategist, shared her positive outlook on the stock market in an interview on CNBC. With major tech companies, consumer, and financial companies set to announce results, she believes that if corporate earnings remain strong, the recent market rebound could continue. Since early April, the market has recovered significantly, and she attributed the rally to better-than-expected profit margins and steady corporate performance. Although the prominent tech names aren't cheap in terms of valuation, she views the recent declines as long-term buying opportunities. While markets may remain volatile in the coming months, the best opportunities in the Dow over the next 12 months should come from stocks with strong pricing power and earnings momentum. Investors should stick to stocks with strong brands, recurring revenue models, and competitive moats, which enable them to navigate macro uncertainty. Since the Dow comprises large-cap companies across various industries, these stocks might perform better during sell-offs. To identify the best and worst Dow stocks, we began with the 30 constituent stocks of the DJIA Index. We then ranked these stocks in ascending order based on the consensus 1-year median potential upside. Additionally, we also include data on hedge funds holding stakes in these stocks, utilizing Insider Monkey's Q4 2024 hedge fund database to provide deeper insights into institutional investor trends. It is important to note here that the terms 'best' and 'worst' refer strictly to the relative upside potential and do not imply any fundamental strengths or weaknesses of the underlying are we interested in the stocks that hedge funds pile into? The reason is simple: our research has shown that we can outperform the market by imitating the top stock picks of the best hedge funds. Our quarterly newsletter's strategy selects 14 small-cap and large-cap stocks every quarter and has returned 363.5% since May 2014, beating its benchmark by 208 percentage points (see more details here). A commercial jetliner parked at an airport, reflecting the companies success in Boeing Company (NYSE:BA) is an aerospace company that manufactures and sells commercial jet aircraft, defense products, and security and space systems to customers in more than 150 countries. The company had a pretty difficult 2024 as it faced issues regarding quality and safety in its aircraft, management churn, and employee strikes. Its share price tanked around 32% last year. In 2025, the company tried to shore up its operations, and the most crucial decision it took was to sell portions of its Digital Aviation Solutions business, including its Jeppesen, ForeFlight, AerData, and OzRunways assets, to the investment firm Thoma Bravo. The deal, announced on April 22, is valued at $10.6 billion. It not only gives The Boeing Company (NYSE:BA) financial leeway but is also expected to strengthen its focus on core business. The company also reported its Q1 2025 results on April 23. The main takeaway was the operational improvement underway. Revenue for the quarter grew 18% year-over-year to $19.5 billion, primarily driven by 130 commercial deliveries. Adjusted core operating profit came in at $199 million, a substantial improvement over an operating loss of $388 million in the prior year. Free cash flow burn (i.e., cash usage) also improved to $2.3 billion versus $3.9 billion for the previous year's quarter. Analysts have been broadly optimistic about the company's operational improvements and outlook. Consensus 1-year median price target currently stands at $200, which implies over 16% upside potential. Overall, BA ranks 16th on our list of best and worst dow stocks for the next 12 months. While we acknowledge the potential of Dow stocks, our conviction lies in the belief that AI stocks hold greater promise for delivering higher returns and doing so within a shorter time frame. There is an AI stock that went up since the beginning of 2025, while popular AI stocks lost around 25%. If you are looking for an AI stock that is more promising than BA but that trades at less than 5 times its earnings, check out our report about this . READ NEXT: 20 Best AI Stocks To Buy Now and 30 Best Stocks to Buy Now According to Billionaires. Disclosure: None. This article is originally published at Insider Monkey. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
